BioGenerator Ventures creates, builds, and invests in companies that are solving important problems in human health and agriculture.

BioGenerator Ventures

BioGenerator Ventures creates, builds, and invests in companies that are solving important problems in healthcare and agriculture.

May 14-16, BioGenerator will co-host a 5-part workshop covering all aspects of writing and submitting an SBIR/STTR proposal to the National Institutes of Health (NIH). 

The first webinar will cover which federal agencies participate, how funds can be used, etc. The next 4 workshops will go over each section of your proposal, including Specific Aims, Research Strategy, Human Subject Research, and more. 

We'll also look at NIH’s commercialization plan, including the value of your project and IP protection. Learn more and register today:https://bit.ly/4dxCYug

BioGenerator Ventures is delighted to announce a recent equity investment in St. Louis-based INTENT, an ag industry pioneer. The investment is intended to help accelerate INTENT’s industry-changing advancements in agriculture, with particular emphasis on INvision Trials software. 

This new software offers a completely redesigned interface for project management, presenting a geospatial visualization of all aspects of a field project in a scalable system that delivers quality data and powerful insights, with speed and agility.

“BioGenerator Ventures is excited to be part of INTENT and sees great value in the insights the company’s technology provides to both innovators and farmers,” said Matt Helms, Managing Director of BioGenerator Ventures, who joined the INTENT board of directors. “INTENT helps translate innovative new technologies to the real-world challenges that farmers must overcome.”

Read more: https://bit.ly/3PJsdvj

Ready to learn key information about SBIR/STTR funding – and gain insights into how to craft a competitive proposal that meets the unique requirements of the National Institutes of Health? Be sure to sign up for the *free* webinar series hosted by BioGenerator and BBC Entrepreneurial Training & Consulting. The sessions run September 19-21 and the registration link is here: https://bit.ly/3Pgqg8a

Now hiring: BioGenerator Ventures is looking for a talented and ambitious Healthcare Executive in Residence to assist BioGenerator’s team in building promising new St. Louis companies, and to help BioGenerator Ventures’ portfolio of more than 50 active companies. 

Through its Executive in Residence (EIR) program, BioGenerator supports a group of experienced business leaders to help build the next generation of St. Louis technology companies. 

Learn more and apply: https://bit.ly/3XU3OW8

Have you registered? Beginning 𝘁𝗼𝗺𝗼𝗿𝗿𝗼𝘄, BioGenerator will co-host a 5-part workshop covering all aspects of writing and submitting an SBIR/STTR proposal to the National Institutes of Health (NIH). 

The sessions run from May 14 to May 16 and will give participants a leg up in this competitive process. The first webinar will cover which federal agencies participate, how funds can be used, and other key fundamentals. 

The next 4 workshops will go over each section of your proposal, including Specific Aims, Research Strategy, Human Subject Research and more. We'll also look at NIH’s commercialization plan, including the value of your project and IP protection. Register now! https://bit.ly/49RiUA0

By helping startups secure financing and develop plans to scale up, BioGenerator Ventures gives new companies the solid footing they need to succeed long-term in St. Louis. Having that foundation is vital for supporting tech job opportunities, which have dropped precipitously over the past year, according to a recent report.

Listen to this story from St. Louis Public Radio to learn more about BioGenerator's important role in the St. Louis startup landscape.

Metric
Company Name	BioGenerator Ventures
Symbol
MSH ID	COM:BIOGENERATORVENTURES
Market	PRIVATE
Sector	Financial Services & Finance
Industry	Venture Capital
Country	US
Stage
Employee Count	36
Website	biogeneratorventures.com
LinkedIn	biogeneratorventures
Founders

Metric
Market Cap
Enterprise Value
Monthly Web Traffic
Web Traffic Growth
Valuation
Raised Capital

Metric
Revenue
Revenue (LTM)
Revenue (NTM)
Gross Profit
EBITDA
Operating Income
Net Income
EPS
Diluted EPS
Revenue 2022
Revenue 2023
Revenue 2024
Revenue 2025
Revenue 2026

Metric
Revenue Growth (LTM)
Revenue Growth (NTM)
Gross Profit Growth (LTM)
EBITDA Growth (LTM)
Net Income Growth (LTM)
14-Day Growth Score
28-Day Growth Score
90-Day Growth Score
365-Day Growth Score

Metric
Gross Profit Margin
Operating Profit Margin
EBITDA Margin
Net Profit Margin
Return on Equity
Return on Assets
Return on Capital Employed

BIOG

COM:BIOGENERATORVENTURES

BioGenerator Ventures

Company Overview

Market Metrics

Financial Performance

Growth Metrics

Profitability Ratios

Valuation Multiples

Operational Metrics

Cash Flow Metrics

Balance Sheet Metrics

Efficiency Metrics

Metric
P/E Ratio
P/B Ratio
Revenue Multiple (LTM)
Revenue Multiple (NTM)
EBITDA Multiple (LTM)
EBITDA Multiple (NTM)
Price to Sales Ratio
EV Multiple

Metric
Days Sales Outstanding
Days Payables Outstanding
Days Inventory Outstanding
Operating Cycle
Cash Conversion Cycle
Asset Turnover

Metric
Operating Cash Flow
Free Cash Flow
Cash Flow to Debt
Operating Cash Flow/Sales
Free Cash Flow Yield

Metric
Cash & Equivalents
Accounts Receivable
Inventory
Goodwill
Debt to Capitalization
Debt to Assets
Current Ratio
Quick Ratio

Metric
Rule of 40 (LTM)
Rule of 40 (NTM)
Stock Comp to Revenue
R&D to Revenue
SG&A to Revenue